课题基金 / 基金详情

PHASE III STUDY OF UVAR PHOTOPHERESIS SYSTEM IN TREATMENT OF SYSTEMIC SCLEROSIS

PHASE III STUDY OF UVAR PHOTOPHERESIS SYSTEM IN TREATMENT OF SYSTEMIC SCLEROSIS
UVAR光采系统治疗系统性硬化症的III期研究
批准号：
6245701
负责人：
BRIAN JEGASOTHY
金额：
$1.76万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-03-18 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6245701
关键词：
clinical research human subject human therapy evaluation photosensitizing agents skin disorder ultraviolet therapy

项目摘要

项目成果

BRIAN JEGASOTHY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this phase 3 study is to assess the stafety and efficacy of the UVAR Photopheresis system in conjunction with Lipid Methoxsalem (UVADEX) in the treatment of the skin manifestations of patients with early onset systemic sclerosis by comparing patients treated with "active" photopheresis therapy against patients receiving "placebo" photopheresis therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE III RANDOMIZED TRIAL OF TWO DOSE DA389IL-2 IN CTCL <3 PREVIOUS TREATMENTS
PHASE I STUDY OF BMS-188667 IN PATIENTS WITH PSORIASIS VULGARIS
MULTICENTER PHASE 3 TRIAL OF DAB3891L-2 IN CTCL PATIENTS IN STAGE IA-IVA DISEASE
PHASE III RANDOMIZED TRIAL OF TWO DOSE DA389IL-2 IN CTCL <3 PREVIOUS TREATMENTS
海外基金